<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 12 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Helvetica;
panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0in;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.EmailStyle18
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:1712613969;
mso-list-type:hybrid;
mso-list-template-ids:-2045052666 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level2
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level3
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level4
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level5
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level6
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
@list l0:level7
{mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level8
{mso-level-number-format:alpha-lower;
mso-level-tab-stop:none;
mso-level-number-position:left;
text-indent:-.25in;}
@list l0:level9
{mso-level-number-format:roman-lower;
mso-level-tab-stop:none;
mso-level-number-position:right;
text-indent:-9.0pt;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="2050" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="color:#1F497D">Karen/IAG Participants, please find additional comments on P1, and P2 along with initial comments on P3 and P5 attached.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">The comments and flows attempt to address many of the topics / questions raised by participants, and the business requirements as described in the discussion draft.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Thanks,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D">Will<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<div>
<div>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="371" style="width:278.25pt">
<tbody>
<tr>
<td colspan="2" style="padding:0in 0in 0in 0in">
<p class="MsoNormal"><span style="color:#1F497D"><img width="371" height="2" id="_x0000_i1025" src="cid:image001.gif@01CCB8F2.4C78E6D0" alt="Verisign"></span><span style="font-size:12.0pt;color:#1F497D"><o:p></o:p></span></p>
</td>
</tr>
<tr>
<td style="padding:11.25pt 0in 15.0pt 0in">
<p class="MsoNormal" style="line-height:10.5pt"><b><span style="font-size:9.0pt;font-family:"Helvetica","sans-serif";color:#006AAA">Will Shorter</span></b><span style="font-size:8.5pt;font-family:"Helvetica","sans-serif";color:#6B6D71"><br>
Product Management<br>
wshorter@verisign.com<br>
<br>
m: 703-932-6609 t: 703-948-3806<br>
21345 Ridgetop Circle, Dulles, VA, 20166<br>
<br>
<a href="http://www.verisigninc.com/"><span style="font-size:9.0pt;color:#006AAA;text-decoration:none">VerisignInc.com</span></a>
<o:p></o:p></span></p>
</td>
<td valign="top" style="padding:11.25pt 0in 0in 0in">
<p class="MsoNormal"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" alt="Verisign™" style='position:absolute;margin-left:3.55pt;margin-top:0;width:54.75pt;height:48pt;z-index:1;visibility:visible;mso-wrap-style:square;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;mso-position-horizontal:right;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:line' o:allowoverlap="f">
<v:imagedata src="cid:image002.gif@01CCB8F2.710CC340" o:href="file:///C:\Users\wshorter\AppData\Roaming\Microsoft\Signatures\logo.gif" />
<w:wrap type="square" anchory="line"/>
</v:shape><![endif]--><![if !vml]><img width="73" height="64" src="cid:image002.gif@01CCB8F2.710CC340" align="right" alt="Verisign™" v:shapes="Picture_x0020_2"><![endif]><span style="font-size:12.0pt;color:#1F497D"><o:p></o:p></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
</div>
<p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
<div>
<div style="border:none;border-top:solid #B5C4DF 1.0pt;padding:3.0pt 0in 0in 0in">
<p class="MsoNormal"><b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif"">From:</span></b><span style="font-size:10.0pt;font-family:"Tahoma","sans-serif""> tmch-iag-bounces@icann.org [mailto:tmch-iag-bounces@icann.org]
<b>On Behalf Of </b>Karen Lentz<br>
<b>Sent:</b> Wednesday, December 07, 2011 2:44 PM<br>
<b>To:</b> tmch-iag@icann.org<br>
<b>Subject:</b> [Tmch-iag] Materials for 16 Dec 11 IAG calls<o:p></o:p></span></p>
</div>
</div>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Dear Colleagues,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Thanks again for the useful submissions and participation on the last IAG call on 30 November.
<br>
<br>
For those who were not able to attend, materials from the call are posted<br>
at <a href="https://community.icann.org/display/cctrdmrkclrnghsiag/Home">https://community.icann.org/display/cctrdmrkclrnghsiag/Home</a>, including<br>
slides, documents, chat transcript and audio recording.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Note that any follow up submissions on the issues P1 and P2 are due by
<b>Monday,</b> <b>12 December</b>. We’ll provide a brief update to those 2 issues after review of all the materials.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><b>Schedule<o:p></o:p></b></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">For the call schedule going forward, note that there are 2 tracks that will proceed in parallel: the process track (focusing on business process development, as now underway) and the technical track (focusing on technical implementation
issues).<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Therefore, on 16 December, there will be 2 calls taking place:<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo2"><![if !supportLists]><span style="mso-list:Ignore">1.<span style="font:7.0pt "Times New Roman"">
</span></span><![endif]>Process call (issues P3 and P5) at <b>13:00 UTC</b>.<o:p></o:p></p>
<p class="MsoListParagraph" style="text-indent:-.25in;mso-list:l0 level1 lfo2"><![if !supportLists]><span style="mso-list:Ignore">2.<span style="font:7.0pt "Times New Roman"">
</span></span><![endif]>Technical call (issues T1 and T3) at <b>16:00 UTC</b>.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Both calls are scheduled for 90 minutes and will use the existing dial-in number and Adobe Connect room.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">You may choose to attend both calls, if you wish, or focus only on one you are interested in. The relevant documents for both are attached.<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt"><b>Process Track<o:p></o:p></b></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">Issue# P3 (Responsibility for Trademark Holder Registration Notice)
<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">Issue# P5 (Responsibility to Perform Trademark Claims Checks)
<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">We will discuss these topics, informed by your written comments, on the
<b>16 Dec call</b>. Please submit your written comments to these issues by <b>13 Dec 2011</b> (23:59 UTC) to the mailing list.<br>
<br>
As discussed previously, we are ultimately seeking your recommendations<br>
for either (1) one of the proposed options in the document or (2) your<br>
suggestions for alternatives that you believe to be more attractive and<br>
that should be considered.<br>
<br>
In your written comments, please make sure to indicate: (a) the issue<br>
number (P3 or P5), (b) the recommended option or alternative for the issue,<br>
(c) rationale (consideration of advantages and how any disadvantages could<br>
be minimized) and (d) any other comments.<br>
<br>
<b>Technical Track</b><o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">Issue# T1 (Data Locations) <o:p>
</o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">Issue# T3 (Communication Protocols)
<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">We will discuss these topics, informed by your written comments, on the
<b>16 Dec call</b>. Please submit your written comments to these issues by <b>13 Dec 2011</b> (23:59) UTC to the mailing list.<br>
<br>
We are ultimately seeking your recommendations for either (1) one of the<br>
proposed options in the document or (2) your suggestions for alternatives<br>
that you believe to be more attractive and that should be considered.<br>
<br>
In your written comments, please make sure to indicate: (a) the issue<br>
number (T1 or T3), (b) the recommended option or alternative for the issue,<br>
(c) rationale (consideration of advantages and how any disadvantages could<br>
be minimized) and (d) any other comments.<br>
<br>
We look forward to hearing from you.<br>
<br>
Karen Lentz<br>
ICANN<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt"><o:p> </o:p></p>
</div>
</div>
</body>
</html>